Idiopathic pulmonary fibrosis
IPF · R&I · 1 drugs · 1 indications
Progressive scarring of the lungs with unknown cause.
Competitive Landscape (1 drugs)
| Drug | Company | Mechanism | Modality | Route | Stage |
|---|
| LTSE-2578 | GPCR | LPA1 receptor antagonist | Small molecule | ORAL | PHASE1 |
Indications (1)
Idiopathic pulmonary fibrosis
Upcoming Catalysts
LTSE-2578 - IPF - Ph2 Potential StartCLINICAL
GPCR2026
Data from Supabase · Updated 2026-03-24